The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.
Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...
In its first meeting of 2025, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the green light for the first vaccine in the EU to protect adolescents ...
PRINCETON, N.J. - Bristol Myers Squibb (NYSE: BMY), a prominent pharmaceutical company with a market capitalization of nearly $120 billion and impressive gross profit margins of 76%, received a ...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) backed approval of Recarbrio at its meeting last week, a few months after the drug was approved by the ...
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 31 JANUARY 2025 AT 19.00 P.M. EET, OTHER INFORMATION DISCLOSED TO THE RULES OF THE EXCHANGE The Shareholders' Nomination Committee proposes the ...
Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...
With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...
RAHWAY, N.J. - Merck & Co ., Inc. (NYSE:MRK) has received a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for its pneumococcal ...
The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked conditions ...
Genetically modified animals have even been used to grow transplant tissues and human transplant organs ... respondents believed that biotech food products would benefit them or their families ...